Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Change in Accured Expenses (2018 - 2025)

Serina Therapeutics' Change in Accured Expenses history spans 8 years, with the latest figure at $316000.0 for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 339.39% to $316000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $18000.0, a N/A change, with the full-year FY2025 number at $18000.0, changed N/A from a year prior.
  • Change in Accured Expenses hit $316000.0 in Q4 2025 for Serina Therapeutics, up from -$183000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for SER hit a ceiling of $403000.0 in Q1 2024 and a floor of -$597000.0 in Q2 2024.
  • Historically, Change in Accured Expenses has averaged -$10789.5 across 5 years, with a median of -$50000.0 in 2023.
  • Biggest five-year swings in Change in Accured Expenses: surged 483.33% in 2022 and later tumbled 3800.0% in 2023.
  • Tracing SER's Change in Accured Expenses over 5 years: stood at -$2000.0 in 2021, then changed by 0.0% to -$2000.0 in 2022, then tumbled by 3800.0% to -$78000.0 in 2023, then crashed by 69.23% to -$132000.0 in 2024, then surged by 339.39% to $316000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for SER at $316000.0 in Q4 2025, -$183000.0 in Q3 2025, and $273000.0 in Q2 2025.